By Stephen U. Lester The full story of dioxin is a complex one, and includes coverups, lies, and deceit; data manipulation by corporations and government; and fraudulent claims and faked studies. For the public, it is a story of pain, suffering, anger, betrayal, and rage; of birth defects, cancer and many uncertainties about health problems. […]
In Utero Workplace Injuries: Children Harmed By Solvents During Pregnancy
Children who have been injured as a result of the negligent conduct of employers who expose pregnant mothers to hazards in the workplace are now entitled to bring a direct action against the mother’s employer in California as a result of a long prayed for September 25, 1996 decision of the California Court of Appeal […]
Dioxin Proven to Cause Cancer and Heart Disease
A major break through in understanding the effect of dioxin exposure was published in December 1995 by Dieter Flesch-Janys and others, “Exposure to Polychlorinated Dioxins and Furans (PCDD/F) and Mortality in a Cohort of Workers from Herbicide-producing Plant in Hamburg, Federal Republic of Germany,” 142 American Journal of Epidemiology 1165-1175 (December 1, 1995). The work […]
Dioxin in Pentachlorophenol: A Case Study of Cancer Deaths in the Lumber Industry
A major break through in understanding the effect of dioxin exposure was published in December 1995 by Dieter Flesch-Janys and others, “Exposure to Polychlorinated Dioxins and Furans (PCDD/F) and Mortality in a Cohort of Workers from Herbicide-producing Plant in Hamburg, Federal Republic of Germany,” 142 American Journal of Epidemiology 1165-1175 (December 1, 1995). Dr. Flesch-Janys […]
Contaminated L-Tryptophan and 5-Hydroxy-L-Tryptophan, Eosinophilia Myalgia Syndrome [EMS], the 1989 Epidemic and the 1998 Warning
In 1998 scientists with the U.S. Food and Drug Administration confirmed the presence of impurities in some 5-hydroxy-L-tryptophan (5-HTP) products currently sold and widely promoted as dietary supplements in health food and nutrition stores. The impurity identified in 5-HTP by spectroscopic analysis is called “peak X.” FDA’s analytical results are consistent with those obtained and […]